Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.

Celik, Tuba; Turkoglu, ELİF

doi:10.3109/02713683.2013.827213

Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.

Celik T., Turkoglu E. B.

Current eye research, cilt.39, sa.1, ss.42-6, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39 Sayı: 1
Basım Tarihi: 2014
Doi Numarası: 10.3109/02713683.2013.827213
Dergi Adı: Current eye research
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.42-6
Anahtar Kelimeler: Fluorometholone, ketorolac, seasonal allergic conjunctivitis, LOTEPREDNOL ETABONATE, OPHTHALMIC SOLUTION, OCULAR ALLERGY, EFFICACY, HYDROCHLORIDE, 0.2-PERCENT, SUSPENSION, COMFORT, SODIUM, DRUGS
Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the therapeutic effects of low-effective steroid fluorometholone 0.1% and non-steroidal anti-inflammatory ketorolac 0.4% when concomitantly used with olopatadine 0.01% in relieving clinical signs and symptoms of acute seasonal allergic conjunctivitis (SAC).